Sign In
Buy PHYOF
$0.0700
+0 (+0%)
At Close: Jul 13, 2026
IXICO guidance unchanged after Huntington's cancellations
03:37am, Monday, 13'th Jul 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after...
IXICO guidance unchanged after Huntington's cancellations
02:42am, Monday, 13'th Jul 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after two clients discontinued Huntington's disea
South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates
07:52am, Wednesday, 08'th Jul 2026
South32 Ltd (LSE:S32, ASX:S32, FRA:32Z, OTC:SHTLF, JSE:S32) has secured a major US federal approval for its US$4.7 billion Hermosa critical minerals project...
IXICO lifts revenue forecast on contract wins and wider client base - UPDATE
06:10am, Tuesday, 07'th Jul 2026
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, rose 11% to 9p after it has raised its revenue forecast for the...
IXICO lifts revenue forecast on contract wins and wider client base
02:22am, Tuesday, 07'th Jul 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, has raised its revenue forecast for the current financial year after stronger-than-expected trading. The company now expects
SpaceX stock surges in hotly anticipated market debut
08:12am, Friday, 12'th Jun 2026
SpaceX (NASDAQ:SPCX)’s closely watched public debut is off to a flying start. The stock, trading under $SPCX, opened at $150 after pricing its IPO at $135 —...
IXICO expands scientific network in Alzheimer's and Parkinson's disease
02:39am, Monday, 08'th Jun 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has expanded its scientific network in Alzheimer's and Parkinson's disease, adding three senior specialists to its advisory board and launching new Parkinson's
Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy
08:33am, Tuesday, 26'th May 2026
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured a proposed international nonproprietary name (pINN) from the World Health Organization for its...
Walmart price target lowered by UBS as Q1 results miss elevated expectations
07:48am, Monday, 25'th May 2026
Walmart Inc (NYSE:WMT, XETRA:WMT) had its price target lowered by UBS to $141 from $147 following the company’s first-quarter results, while the broker said...
Bram Goorden discusses IXICO growth plans - ICYMI
03:50am, Sunday, 24'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company’s interim results, highlighting strong revenue growth,...
Bram Goorden discusses IXICO growth plans - ICYMI
03:06am, Sunday, 24'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company's interim results, highlighting strong revenue growth, expanding demand in Alzheimer's disease clini
IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
05:10pm, Thursday, 21'st May 2026
IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
Zscaler set to benefit from federal tailwinds boosting fourth quarter outlook: analysts
10:30am, Thursday, 21'st May 2026
Zscaler Inc. (NASDAQ:ZS) is expected to deliver a strong fiscal third quarter when it reports results on May 26, with Jefferies analysts saying the...
IXICO contract wins provide near-total revenue visibility for current year
06:51am, Thursday, 21'st May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured £1.3 million of new contract work that its broker says should take the company's order book close t
IXICO wins £1.3 million in Alzheimer's and Huntington's contracts
02:24am, Thursday, 21'st May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured a contract win and a contract extension worth a combined £1.3 million over two years. The London-ba
